Matthew is a life sciences industry lawyer who focuses his practice on achieving the business goals of clients. This includes patent portfolio development and strategic patent prosecution; counseling with regard to FDA regulatory issues and their intersection with intellectual property; litigation in federal district court; and inter partes proceedings before the Patent Trial and Appeal Board.

Matthew has a particular expertise in the pharmaceutical, life science and medical device fields. He draws on this experience to assist clients in the identification of products as business development opportunities and to obtain and maneuver through intellectual property hurdles by coordinating due diligence, preparing patent validity, freedom-to-operate and non-infringement opinions, and resolving disputes in Federal District Court and before the U.S. Patent and Trademark Office.

Prior to entering private practice at prominent Washington, D.C. firms, Matthew worked at the United States Patent and Trademark Office where he was responsible for patent applications relating heterocyclic organic chemistry in the pharmaceutical and carbohydrate fields. Prior to this, he worked at the U.S. FDA’s Office of Generic Drugs in the Center for Drug Evaluation and Research.

Matthew was selected for inclusion in the IAM Patent 1000 – The World’s Leading Patent Practitioners, 2014-2020; Virginia Rising Stars, 2014-2015; Washington, D.C. Rising Stars, 2014-2015; and Washington, D.C. Super Lawyers in 2020-2021.